ISO 22716 Certification for Bright Innovation Labs Ohio

Quality you can trust starts with responsible manufacturing. PRCA’s Good Manufacturing Practices (GMP) Seal recognizes companies that follow strict standards for receipt production, including accuracy, consistency, and responsible materials. It’s a commitment to quality that benefits retailers and consumers alike. Learn more about the GMP program: https://bit.ly/3JPCQYx

We've just launched a FREE 10-minute guide to choosing an EU/UK cosmetics manufacturer. Your choice of manufacturer affects everything from product quality and regulatory exposure to speed to market and your ability to scale. Yet it's a decision that often gets less scrutiny than it deserves. In our guide, we break down what to look for, including: ➡️ Regulatory essentials (Responsible Person requirements, PIF compilation and CPNP/SCPN notification) ➡️ Manufacturing standards (GMP compliance and ISO 22716 certification) ➡️ Technical capability (formulation services, product formats and MOQs) ➡️ Testing (stability, microbiological and challenge testing) ➡️ Claims (substantiation requirements and certification support) ➡️ Scale (lead times, supply chain resilience and capacity planning) Whether you're launching your first product or reviewing an existing manufacturing relationship, our guide will help you make a more informed choice. There's a link to read it in the comment section below.

Secondary packing in OSD is where product integrity, patient safety, regulatory compliance, and supply-chain traceability all converge on one line, in real time, at speeds of up to 600 units per minute. After months of working on compliance on packaging lines across India and globally, I've distilled everything into a comprehensive slide reference deck covering: → The full 10-stage packing line (with pictorial diagrams) → Cartoning machine operation — zone by zone → GMP pillars with exact Schedule M & ICH Q7 requirements → Serialization, aggregation hierarchy, DSCSA & EU FMD mandates → Checkweigher + Vision inspection — how 100% inspection works → 6 common defects with risk ratings and prevention controls → Complete IPQC parameter table → Deviation management and CAPA protocols → All 12 machines on a secondary line explained → Packaging material specifications (board, film, label) → Batch record flow — before, during and after → GDP storage zones and EU GDP requirements → 8 global regulations in one slide This isn't theory. This is what auditors check. This is what regulators expect. This is what patients depend on. Swipe through all slides 👉 💬 What is the one thing on your secondary packing line that keeps you up at night? Drop it below — let's learn together #OSD #SecondaryPacking #GMP #PharmaceuticalManufacturing #Serialization #QualityAssurance #ScheduleM #DSCSA #EUFMD #IPQC #BatchRecord #GDP #PackagingLine #PharmaCompliance #DrugManufacturing #ICH #Cartoning #QualityControl #Regulatory

Reposting this because it perfectly captures something people don’t always see about the beauty industry. The campaigns are beautiful. But the real work behind successful brands is operational discipline. And once the product is made, there’s another layer most people don’t see, kitting, retail prep, PR mailers, and fulfillment. At CPM Solutions, we work in that space every day helping brands get products where they need to go. Huge respect for the teams doing the behind-the-scenes work that makes launches possible. #3PL Services #turnkey #teamwork

MoCRA compliance deadlines are closer than you think, and they might redefine what 'compliance-ready' means for your team. The Modernization of Cosmetics Regulation Act (MoCRA) introduces sweeping updates to U.S. cosmetic regulations. But here's the surprising part: many of the requirements don’t just affect future formulations. They apply retroactively to products already on the market. This retroactive scope is where things get tricky. If you’re assuming your existing portfolio is exempt, think again. With MoCRA, brands must ensure proper registration, adhere to updated safety substantiation requirements, and maintain meticulous records,even for legacy SKUs. Non-compliance isn’t just a missed deadline; it risks product removals, penalties, and lost consumer confidence. At NanoCompass OS, we’ve been analyzing how MoCRA intersects with our system’s monitoring of FDA feeds. Here’s what stands out: retroactive checks are catching teams off guard. In one scenario, a nano-cosmetic ingredient flagged for review five years ago now requires immediate documentation under MoCRA’s updated rules. Imagine the cost if this wasn’t caught pre-deadline. For compliance teams, this isn’t about scrambling to check boxes,it’s about adopting a new mindset. Systems that continuously audit, validate, and monitor for emerging changes aren't just helpful, they're essential. So here’s the real question: How is your team approaching retroactive compliance under MoCRA? Are legacy products part of your strategy, or are they slipping through the cracks? #CosmeticRegulation #MoCRA #FDA

⚠️ GMP Debate for the Industry During an inspection, an auditor reviews a deviation. The root cause states: 👉 “Operator error” CAPA: 👉 “Operator retrained” On paper… everything looks addressed. But let’s challenge this: Was the problem really the operator? In many GMP environments, “operator error” becomes a default answer. But often the real issues are: Poorly designed procedures Lack of practical training Unclear instructions under pressure Weak quality culture So here’s the debate: 👇 What’s the REAL root cause in most cases? A) Operator error B) System / process design failure C) Training effectiveness gap Because if we keep blaming operators… 👉 We might be missing the system failures entirely. Curious to hear from others: What do you see most during audits and inspections? #GMP #PharmaceuticalIndustry #Biotech #QualityAssurance #CAPA #RootCauseAnalysis #InspectionReadiness #GxP

#GMPHabits. 1. In pharmaceutical manufacturing—especially in sterile and parenteral production—personal hygiene is not merely a matter of appearance; it is a critical element of GMP compliance and product safety. 2. Beards are generally discouraged in manufacturing areas because facial hair can shed particles, skin flakes, and microorganisms that may contaminate the product. 3. Even with beard covers, the risk of particle shedding remains cannot be ruled out. 4.. This concern becomes far more serious in parenteral manufacturing, where the product goes directly into the bloodstream. 5. Equally important is nail hygiene. Long nails, artificial nails, or poorly maintained nails can harbor microbes and particulate matter. 6. Cleanroom practices therefore require short, clean, well-maintained nails, with no nail polish or artificial extensions. 7. For pharmacy students and freshers aspiring to work in production, QA, or sterile manufacturing, it is wise to understand these expectations early. 8. Technical knowledge alone is not enough. Cleanroom discipline, personal hygiene, and contamination awareness are integral professional competencies. 9. Preparing for a career in pharmaceutical manufacturing begins with adopting these GMP habits even before entering the industry. Thank you Mr Kishore Shinde for the post.. 👍 #PharmacyStudents #Freshers #Pharmacists #APTI #AIPDA

Is it worth getting ISO certified? None of our current clients are pushing us for it. There are some prospects it might help with but no guarantee certainly. Our quality management and internal practices are already built on ISO and cGMP principles. I don't know that the lift would be enormous...maybe? I can see some upside but ISO certification also seems rare in the label & tag space. Curious to hear your thoughts/experience with ISO certification.

MoCRA compliance doesn't have to be a moving target. If you export cosmetics or OTCs to the U.S., follow this practical checklist to meet MoCRA requirements and avoid enforcement risk. 1) Designate a U.S. Agent under 21 CFR 1.225. You must have a legally appointed U.S. Agent before importing. 2) Complete FDA Facility Registration (21 U.S.C. 360(i)) and keep it updated annually or within 60 days of ownership change. 3) Implement product listing and adverse event reporting processes per 21 CFR Part 803 (for consumer reports) and MoCRA adverse event timelines. 4) Conduct a labeling review for mandatory statements (ingredient declaration, warning statements, and required English-language labeling) and substantiation of safety claims. 5) Establish lot-level traceability and record-retention procedures to meet inspection requests and reporting windows. 6) Assign a single point of contact to coordinate recalls, inspections, and FDA communications. Axentra offers fixed-fee, full-service support: U.S. Agent designation, facility registration, labeling review, adverse-event workflow setup, and one dedicated regulatory lead — all billed transparently rather than hourly. That approach streamlines your timeline and gives you a single accountable contact for FDA interactions. Learn how we map these steps to your product portfolio and timelines: https://lnkd.in/gsXPBNvQ #RegulatoryAffairs #MoCRA #CosmeticsCompliance